GVG, known as vigabatrin in the 70 countries where it is used for treating epilepsy, has a unique mechanism of action. Dr. Stephen Dewey of BHL explains to host Dr. Leslie Lundt his research into this compound and how it potentially could change the course of addictive disorders.
GVG, known as vigabatrin in the 70 countries where it is used for treating epilepsy, has a unique mechanism of action. Dr. Stephen Dewey of BHL explains to host Dr. Leslie Lundt his research into this compound and how it potentially could change the course of addictive disorders.
